• Seema @seema2 ·  7 years, 4 months ago  ·
    Added BIOCON to watchlist
    The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune.
    Sales Growth > 10% Profit Margin > 15% Attractive Valuation NIFTY NEXT 50 + 10 indices
 
Reply to @seema2
Use @ for users, # for companies and : for emojis
Relevant Companies
Mentioned Users
Trending Today
Leaderboard View more / less  
Loading..
Top Gainers & Losers View more / less
Loading ...